sns insider pvt ltd.png
Personalized Medicine Biomarkers Market Size to Hit USD 58.39 Billion by 2032, Growing at a 14.54% CAGR – SNS Insider
18 févr. 2025 10h00 HE | SNS Insider pvt ltd
Pune, Feb. 18, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, The Personalized Medicine Biomarkers Market size was valued at USD 17.26 billion in 2023, is projected to reach USD 58.39 billion by...
Bio-Hermes-002
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration with Roche for the Transformative Bio-Hermes-002 Study
18 févr. 2025 09h00 HE | Global Alzheimer’s Platform Foundation®
Washington D.C., Feb. 18, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Roche to the Bio-Hermes-002 study. This collaboration will enhance this...
Bio-Hermes-001
Global Alzheimer’s Platform Foundation Announces Powerhouse Partnership with Biomarkers of Aging Consortium
30 janv. 2025 09h01 HE | Global Alzheimer’s Platform Foundation®
Washington D.C., Jan. 30, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to announce a collaboration with the Biomarkers of Aging Consortium, a consortium...
Bio-Hermes-002
Beckman Coulter Diagnostics Joins the Transformative Bio-Hermes-002 Study as New Partner
23 janv. 2025 09h01 HE | Global Alzheimer’s Platform Foundation®
Washington D.C., Jan. 23, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Beckman Coulter Diagnostics as a strategic partner in the Bio-Hermes-002...
tiziana-logo.png
Tiziana Life Sciences Announces Discovery of New Immune Biomarkers in Multiple Sclerosis Patients Treated with Nasal Foralumab
22 janv. 2025 16h05 HE | Tiziana Life Sciences Ltd.
NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with...
FYR logo
FYR Appoints Chris Howlett to its Board of Directors
09 janv. 2025 08h30 HE | FYR Bio
FYR announced the appointment of industry veteran Chris Howlett to its Independent Board of Directors.
Global Alzheimer’s P
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration with Eli Lilly and Company for the Transformative Bio-Hermes-002 Study
09 déc. 2024 10h00 HE | Global Alzheimer’s Platform Foundation®
Washington D.C., Dec. 09, 2024 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome Eli Lilly and Company (Lilly) to the Bio-Hermes-002 study. This...
Biognosys Newton, Massachusetts proteomics facility
IonOpticks’ Custom Chromatography Column to Become Biognosys’ Standard for High-Quality Proteomic Insights
05 déc. 2024 08h00 HE | Biognosys AG
IonOpticks and Biognosys announce a long-term supply agreement. Under the agreement, IonOpticks will supply Biognosys with custom chromatography columns.
Collaborative effort
Collaborative effort to conduct a study aimed at improving the diagnosis of Alzheimer’s and related dementias for everyone
28 oct. 2024 10h00 HE | Global Alzheimer’s Platform Foundation®
Washington D.C., Oct. 28, 2024 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation® (GAP) is pleased to welcome the initial strategic partners in the Bio-Hermes-002 study. These...
sns insider pvt ltd.png
Companion Diagnostics Market Size Worth US$ 21.15 billion by 2032, Rising Prevalence of Cancer and Advances in Precision Medicine Drives Growth | Research by SNS Insider
09 oct. 2024 09h00 HE | SNS Insider pvt ltd
Pune, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Companion Diagnostics Market Size Analysis: “According to SNS Insider Research, The Companion Diagnostics Market Size was valued at USD 7.66 Billion in 2023,...